2019 AMI Online Salon

Predicting Local Recurrence of Bladder Cancer after Radical Cystectomy

Project Detail

  • Entrant Name: Iman Carr

  • Membership Type: Professional Submission

  • Other Contributors:

  • Address: Buffalo,NY

  • Client: Department of Urology at the Roswell Park Comprehensive Cancer Center

  • Medium/software used: Adobe: After Effects, Illustrator, Premier Pro & Audition

  • Final presentation format: Video

  • Primary Audience: Educated Lay, Urologists, Researchers, Clinicians & Scientists

Project Description

Roswell Park Comprehensive Cancer Center has developed a novel immunotherapy currently open to patients through clinical trials. This animated video is used to inform patients and help them make educated decisions about participating in relevant clinical trials. The presence of cancer-fighting T-cells in tumor microenvironments is critical for the effectiveness of immune therapies and patient outcomes, while regulatory T-cells promote cancer progression. An enzyme, Cyclooxygenase type 2 (COX-2) is blocked to enhance cancer-fighting T-cells and inhibit cancer progression or regulatory T-cells attracted to the tumor.